Midvale, UT, United States of America

Robert Selliah

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Robert Selliah: Innovator in Cancer Treatment**

Introduction

Robert Selliah, based in Midvale, UT, is a distinguished inventor recognized for his significant contributions to the field of cancer research. With four patents to his name, Selliah's innovations focus on compounds and methodologies aimed at effectively combating cancer cells. His work not only holds promise for cancer patients but also advances the pharmaceutical landscape.

Latest Patents

Selliah's latest patents include the groundbreaking development of **3-aryl-substituted quinazolones**, compounds that are designed to effectively kill or reduce the proliferation rate of cancer cells. These compounds are particularly relevant for patients suffering from cancer, as they offer a new wave of hope in treatment options. Furthermore, his patent also encompasses pharmaceutical compositions that integrate these compounds and outlines methods of treatment using them.

Another significant patent revolves around **quinoxaline derivatives as antitumor agents**. This invention is centered on methods of screening for essential binding partners, particularly those crucial for the biological activity of erastin, such as the voltage-dependent anion channels (VDACs) including VDAC3. The invention provides essential reagents and methods for the effective destruction of cancer cells using erastin and its related compounds or derivatives.

Career Highlights

Robert Selliah has made notable strides in his career by working with reputable organizations like Prolexys Pharmaceuticals, Inc. and the Whitehead Institute for Biomedical Research. These affiliations have allowed him to collaborate on cutting-edge research and further his invention pursuits in the biomedical field.

Collaborations

Throughout his career, Selliah has collaborated with esteemed colleagues, including Longwu Qi and Paul B Robbins. Their teamwork has contributed significantly to the innovative progress in cancer treatment and related research enhancements.

Conclusion

Robert Selliah stands out as a visionary inventor in the realm of cancer research. Through his multiple patents and collaborative efforts, he continues to impact the medical industry positively, offering new solutions for the fight against cancer. His work exemplifies the essence of innovation in addressing some of the most pressing challenges in healthcare today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…